, Volume 14, Issue 10–11, pp 631–633 | Cite as

2e Colloque francophone sur les cancers du sein in situ

Actualités de la SFSPM / SFSPM News

Second French-speaking conference on in situ breast cancers


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bartelink H, Horiot JC, Poortmans PM, et al. (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25: 3259–3265PubMedCrossRefGoogle Scholar
  2. 2.
    Cutuli B (2012) Cancers canalaires in situ de moins de 5 mm: pour la radiothérapie postopératoire. Gynecol Obstet Fertil 40: 384–386PubMedCrossRefGoogle Scholar
  3. 3.
    Cuzick J, Sestak I, Pinder SE, et al. (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal caricinoma in situ: long-term results from the UK/ANZ DCIS trialGoogle Scholar
  4. 4.
    Kirova Y, De Rycke Y, Gambotti L, et al. (2008) Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 98: 870–874PubMedCrossRefGoogle Scholar
  5. 5.
    Riou O, Lemanski C, Guillaumon V, et al. (2012) Role of radiotherapy boost on local control in ductal carcinoma in situ. Int J Surg Oncol (in press)Google Scholar
  6. 6.
    Romestaing P (2012) Cancers canalaires in situ de moins de 5 mm pas de radiothérapie postopératoire. Gynecol Obstet Fertil 40: 387–389PubMedCrossRefGoogle Scholar
  7. 7.
    Vincent-Salomon A, Hajage D, Rousette A, et al. (2012) High Ki67 expression is a marker of invasive relapse for classical lobular carcinoma in situ patients. The Breast (in press)Google Scholar
  8. 8.
    Virnig BA, Tuttle TM, Shamliyan T, Kane RL (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment and outcomes. J Natl Cancer Inst 102: 170–178PubMedCrossRefGoogle Scholar
  9. 9.
    Wapnir IL, Digman JJ, Fisher B, et al. (201) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 1 103: 478–488Google Scholar

Copyright information

© Springer-Verlag France 2012

Authors and Affiliations

  1. 1.Centre Alexis-VautrinVandœuvre-lès-NancyFrance
  2. 2.Institut du cancer CourlancyReimsFrance

Personalised recommendations